SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-128868
Filing Date
2022-12-21
Accepted
2022-12-21 08:10:41
Documents
13
Period of Report
2022-12-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2233167d1_8k.htm   iXBRL 8-K 30226
2 EXHIBIT 99.1 tm2233167d1_ex99-1.htm EX-99.1 20337
  Complete submission text file 0001104659-22-128868.txt   231423

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nbse-20221221.xsd EX-101.SCH 3066
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20221221_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20221221_pre.xml EX-101.PRE 22617
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2233167d1_8k_htm.xml XML 3504
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 221476588
SIC: 2834 Pharmaceutical Preparations